Neil Gregory Almstead Ptc Therapeutics, Inc. (PTCT) insider trading activity

PTCT Quotes by TradingView

Neil Gregory Almstead is CHIEF TECHNICAL OPS OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 103,231 shares of PTCT, which is worth approximately $4.67 Million. The most recent transaction as insider was on Jan 08, 2025, when has been sold 1,552 shares (Common Stock) at a price of $44.5 per share, resulting in proceeds of $69,064. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K
19.75% 3M change
68.67% 12M change
Total Value Held $4.67 Million

Neil Gregory Almstead Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2025
SELL
Open market or private sale
$69,064 $44.5 p/Share
1,552 Reduced 1.48%
103,231 Common Stock
Jan 07 2025
SELL
Open market or private sale
$57,355 $45.34 p/Share
1,265 Reduced 1.19%
104,783 Common Stock
Jan 03 2025
BUY
Grant, award, or other acquisition
-
19,000 Added 15.19%
106,048 Common Stock
Dec 02 2024
SELL
Open market or private sale
$3,638,856 $52.32 p/Share
69,550 Reduced 44.65%
86,202 Common Stock
Dec 02 2024
BUY
Exercise of conversion of derivative security
$3,547,050 $51.0 p/Share
69,550 Added 31.23%
153,158 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 22.48%
86,202 Common Stock
Jan 30 2024
SELL
Open market or private sale
$16,840 $27.25 p/Share
618 Reduced 1.0%
61,202 Common Stock
Jan 09 2024
SELL
Open market or private sale
$44,124 $29.01 p/Share
1,521 Reduced 2.4%
61,820 Common Stock
Jan 08 2024
SELL
Open market or private sale
$35,399 $28.64 p/Share
1,236 Reduced 1.91%
63,341 Common Stock
Jan 31 2023
SELL
Open market or private sale
$28,746 $45.63 p/Share
630 Reduced 0.98%
63,949 Common Stock
Jan 11 2023
SELL
Open market or private sale
$16,989 $44.36 p/Share
383 Reduced 0.59%
64,579 Common Stock
Jan 10 2023
SELL
Open market or private sale
$20,305 $42.93 p/Share
473 Reduced 0.72%
64,962 Common Stock
Jan 09 2023
SELL
Open market or private sale
$29,828 $41.66 p/Share
716 Reduced 1.08%
65,435 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
17,000 Added 20.44%
66,151 Common Stock
Feb 01 2022
SELL
Open market or private sale
$24,200 $40.0 p/Share
605 Reduced 1.22%
48,853 Common Stock
Jan 07 2022
SELL
Open market or private sale
$29,121 $38.52 p/Share
756 Reduced 2.11%
35,058 Common Stock
Jan 07 2022
BUY
Grant, award, or other acquisition
-
14,400 Added 22.55%
49,458 Common Stock
Feb 01 2021
SELL
Open market or private sale
$55,422 $56.96 p/Share
973 Reduced 2.64%
35,814 Common Stock
Jan 06 2021
BUY
Grant, award, or other acquisition
-
10,200 Added 21.71%
36,787 Common Stock
Jan 05 2021
SELL
Open market or private sale
$31,310 $62.37 p/Share
502 Reduced 1.85%
26,587 Common Stock
Jan 04 2021
SELL
Open market or private sale
$6,290,065 $60.81 p/Share
103,438 Reduced 79.25%
27,089 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$1,833,956 $17.73 p/Share
103,438 Added 57.9%
75,214 Common Stock
Nov 04 2020
SELL
Open market or private sale
$1,443,720 $60.0 p/Share
24,062 Reduced 47.04%
27,089 Common Stock
Nov 04 2020
BUY
Exercise of conversion of derivative security
$270,216 $11.23 p/Share
24,062 Added 32.95%
48,964 Common Stock
NGA

Neil Gregory Almstead

CHIEF TECHNICAL OPS OFFICER
South Plainfield, NJ

Track Institutional and Insider Activities on PTCT

Follow PTC THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

News

Receive news related to PTC THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTCT